Related references
Note: Only part of the references are listed.Empirical and Rational Design of T Cell Receptor-Based Immunotherapies
Heather F. Jones et al.
FRONTIERS IN IMMUNOLOGY (2021)
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nisha B. Nagarsheth et al.
NATURE MEDICINE (2021)
Targeting a neoantigen derived from a common TP53 mutation
Emily Han-Chung Hsiue et al.
SCIENCE (2021)
Bispecific antibodies targeting mutant RAS neoantigens
Jacqueline Douglass et al.
SCIENCE IMMUNOLOGY (2021)
Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells
Andrea Lisco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal et al.
FRONTIERS IN MICROBIOLOGY (2020)
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies
Brian H. Santich et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Solving an MHC allele-specific bias in the reported immunopeptidome
Martin G. Klatt et al.
JCI INSIGHT (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery
Philippe Valadon et al.
MABS (2019)
Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
Diego Ellerman
METHODS (2019)
A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes
Renata Blatnik et al.
PROTEOMICS (2018)
Opportunities and challenges for human papillomavirus vaccination in cancer
Richard B. S. Roden et al.
NATURE REVIEWS CANCER (2018)
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
S. Rafiq et al.
LEUKEMIA (2017)
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens (vol 127, pg 2705, 2017)
Aaron Y. Chang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
Lindsey M. Draper et al.
CLINICAL CANCER RESEARCH (2015)
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus-Targeted Tumor-Infiltrating T Cells
Sanja Stevanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
Tao Dao et al.
NATURE BIOTECHNOLOGY (2015)
Therapeutic vaccination against human papilloma virus induced malignancies
Sjoerd H. van der Burg et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers
Angelika B. Riemer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
K Brischwein et al.
MOLECULAR IMMUNOLOGY (2006)
Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct
P Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
Share Paper
